Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 68084-480

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 68084-480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg Blister

Labels for Oxybutynin Chloride Extended Release Tablets USP 10 mg by American Health Packaging. Each label includes the product name, dosage strength of 10 mg, a barcode, NDC number (00368-0840-11), and a placeholder for lot number and expiration date. Labels are arranged in multiple rows and columns on the sheet.*

FDA Label Image

10 mg Carton

Oxybutynin Chloride Extended-Release Tablets USP 10 mg oral tablet label by American Health Packaging. The package contains 30 extended-release tablets (3 blister cards of 10). The label includes dosage form, strength, NDC number 68084-610-21, and storage instructions. The label indicates prescription use only and provides packaging and distributor information.*

FDA Label Image

5 mg Blister

Oxybutynin Chloride Extended Release 5 mg oral tablets packaging label from American Health Packaging. The label includes the drug name, strength, tablet form, lot number 123456, and expiry date 01/18. The label is repeated multiple times on the sheet shown.*

FDA Label Image

5 mg Carton

Label for Oxybutynin Chloride Extended-Release Tablets USP 5 mg oral tablets, supplied in a package of 100 tablets (10 x 10). The label includes dosage instructions, storage conditions, safety warnings, NDC 68084-480-01, and lists American Health Packaging as the distributor.*

FDA Label Image

Ahp48001

Oxybutynin Chloride Extended Release 10 mg oral tablet, white and round with imprint 'K11' on one side and '270' on the opposite side. This extended-release tablet is manufactured by American Health Packaging.*

FDA Label Image

Ahp61021

Oxybutynin Chloride Extended Release 10 mg tablet, oral dosage form. The round white tablet is imprinted with 'KU' on one side and '271' on the other. Manufactured by American Health Packaging.*

FDA Label Image

Figure 1

A line graph comparing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours following administration of oxybutynin chloride extended-release tablets 10 mg once daily (QD) versus oxybutynin 5 mg three times daily (TID). The graph includes error bars showing variability at each time point.*

FDA Label Image

Figure 2

A pharmacokinetic curve showing mean extended-release oxybutynin plasma concentrations (ng/mL) plotted over time in hours, from 0 to 24 hours. The graph includes error bars representing variability in concentration measurements at each time point.*

FDA Label Image

Figure 3

A horizontal error bar chart showing mean change (±SD) in episodes per week from baseline for oxybutynin chloride extended-release tablets and placebo. The chart compares the effect of the extended-release tablets versus placebo on episodes per week, with data points and error bars displayed along a horizontal axis ranging from -40 to 40.*

FDA Label Image

Figure 4

A horizontal bar graph depicting the mean change in episodes per week from baseline for oxybutynin chloride extended-release tablets. The central marker indicates the mean change, with error bars showing the standard deviation range extending to both negative and positive values.*

FDA Label Image

Figure 5

A horizontal bar chart showing mean change with standard deviation in episodes per week from baseline. Two separate bars represent oxybutynin chloride extended-release tablets and oxybutynin. The x-axis ranges from -40 to 40 with markers at -20, 0, 20, and 40.*

FDA Label Image

Structure

Chemical structure diagram of Oxybutynin Chloride, showing its molecular composition with labeled groups and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.